GoHealth, Inc.

How big is GoHealth, Inc.?

As of Jun 18, GoHealth, Inc. has a market capitalization of 62.45 million, with net sales of 834.26 million and a net profit of 4.25 million over the latest four quarters. The balance sheet shows shareholder's funds of 241.84 million and total assets of 1,492.44 million.

As of Jun 18, GoHealth, Inc. has a market capitalization of 62.45 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 834.26 million and a net profit of 4.25 million for the latest four quarters.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 241.84 million and total assets of 1,492.44 million.

What does GoHealth, Inc. do?

GoHealth, Inc. operates a health insurance marketplace that helps individuals find suitable health insurance plans. As of March 2025, it reported net sales of $221 million and a market cap of $62.45 million.

Overview: <BR>GoHealth, Inc. operates a health insurance marketplace leveraging technology to assist individuals in finding suitable health insurance plans, and it belongs to the Capital Markets industry with a micro-cap classification.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 221 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -10 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 62.45 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 6.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: 5.23% <BR>Price to Book: 0.26<BR><BR>Contact Details: <BR>Address: 214 West Huron Street, CHICAGO IL: 60654 <BR>Tel: 1 312 3868222 <BR>Website: https://www.gohealth.com/

Should I buy, sell or hold GoHealth, Inc.?

Who are in the management team of GoHealth, Inc.?

As of March 2022, the management team of GoHealth, Inc. includes CEO and Co-Founder Clinton Jones, along with Directors Rahm Emanuel, Joseph Flanagan, Jeremy Gelber, Miriam Tawil, and Alex Timm.

As of March 2022, the management team of GoHealth, Inc. includes Mr. Clinton Jones, who serves as the Chief Executive Officer, Co-Founder, and Director. The board of directors also consists of Mr. Rahm Emanuel, Mr. Joseph Flanagan, Mr. Jeremy Gelber, Ms. Miriam Tawil, and Mr. Alex Timm, all of whom hold the position of Director.

Is GoHealth, Inc. overvalued or undervalued?

As of August 7, 2025, GoHealth, Inc. is considered a risky investment due to its overvaluation, reflected in low P/E and EV to EBITDA ratios compared to peers, and a significant year-to-date stock decline of -63.7% versus the S&P 500's 12.22% return.

As of 7 August 2025, the valuation grade for GoHealth, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. Based on the current metrics, the company appears to be overvalued. Key ratios include a P/E ratio of 6, an EV to EBITDA of 0.44, and a PEG ratio of 0.05, all of which suggest that the stock is not priced in line with its earnings growth potential.<BR><BR>In comparison to peers, GoHealth's P/E ratio of 2.12 is significantly lower than Crawford & Co.'s fair valuation P/E of 17.88, highlighting a stark contrast in market perception. Additionally, GoHealth's EV to EBITDA ratio of 0.418 is also less favorable compared to its peers. The company's stock has underperformed relative to the S&P 500, with a year-to-date return of -63.7% compared to the index's 12.22%, reinforcing the notion that GoHealth is currently overvalued.

Is GoHealth, Inc. technically bullish or bearish?

As of September 3, 2025, GoHealth, Inc. is in a bearish trend with weak strength, indicated by bearish daily moving averages and Bollinger Bands, while the stock has underperformed significantly over the past year with a return of -48.49% compared to the S&P 500's 17.14%.

As of 3 September 2025, the technical trend for GoHealth, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength. Key indicators include bearish signals from the daily moving averages and Bollinger Bands, while the weekly MACD and KST show mildly bullish readings, indicating some divergence. The Dow Theory is bearish on a monthly basis, and there are no significant signals from the RSI or OBV. Over the past year, GoHealth has underperformed significantly, with a return of -48.49% compared to the S&P 500's 17.14%.